Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2013
08/15/2013US20130210799 Novel azetidine derivatives
08/15/2013US20130210798 Soluble guanylate cyclase activators
08/15/2013US20130210795 Substituted dicyanopyridines and use thereof
08/15/2013US20130210774 Potent and selective inhibitors of hepatitis c virus
08/15/2013US20130210773 Indole compounds as positive allosteric modulators of the muscarinic receptor
08/15/2013US20130210705 Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof
08/15/2013US20130209397 Heterocyclic antiviral compounds
08/15/2013US20130207043 Sterically hindered amine light stabilizers with a mixed functionalization
08/14/2013EP2626355A1 Process for the preparation of nilotinib hydrochloride
08/14/2013EP2626354A1 Viral polymerase inhibitors
08/14/2013EP2626353A1 Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
08/14/2013EP2626352A1 Heterocyclic low-molecular sapp mimetics, a pharmaceutical composition and methods for producing and using same
08/14/2013EP2626350A1 Cyclopropane compound
08/14/2013EP2626348A1 Heterocyclic amides as rock inhibitors
08/14/2013EP2626346A1 Benzo[k]fluoranthene derivative and organic electroluminescence element containing same
08/14/2013EP2625175A1 Crystalline (r) - (e) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1h - indazol - 3 - yl) vinyl) -1 h- pyrazol- 1 -yl) ethanol and its use as fgfr inhibitor
08/14/2013EP2625174A1 Co-crystals and salts of ccr3-inhibitors
08/14/2013EP2625173A2 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
08/14/2013EP2625172A1 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid
08/14/2013EP2625169A1 Quinazoline compounds as sodium channel blockers
08/14/2013EP2625167A1 Salts and polymorphs of sulfamide ns3 inhibitors
08/14/2013EP2625165A1 Insecticidal pyrrolidin-yl-aryl-carboxamides
08/14/2013EP2624697A1 Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators
08/14/2013EP2624696A1 Benzimidazole derivatives as pi3 kinase inhibitors
08/14/2013CN103249729A Anthranilic acid diamide derivatives with cyclical side chains
08/14/2013CN103249728A Novel triazole compounds III
08/14/2013CN103249721A Arylamide derivatives as TTX-S blockers
08/14/2013CN103249719A Matrix metalloproteinase inhibitors
08/14/2013CN103249718A 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres
08/14/2013CN103249414A Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
08/14/2013CN103242308A 2-fluoro pyridine derivatives, as well as preparation method and application thereof
08/14/2013CN103242297A Preparation method of 5-difluoro methoxyl-2-[[(4-chlorine-3-methoxyl-2-pyridyl)-methyl]sulfo-1H-benzimidazole-hydrate
08/14/2013CN103242296A Dabigatran etexilate analogue with fluorine-containing group modified pyridine ring as center and synthesis method of analogue
08/14/2013CN103242295A Esomeprazole sodium crystal-form compound and synthesis method thereof
08/14/2013CN103242294A (S)-pantoprazole sodium dihydrate and preparation method thereof
08/14/2013CN103242293A Salt of quinolyl urea derivative
08/14/2013CN103242292A Polymorphism of desloratadine disodium hydrogen citrate complex salt
08/14/2013CN103242291A Mass production process of polycrystalline high-content benzoic acid alogliptin
08/14/2013CN103242231A Quinoline derivatives as well as preparation methods and applications thereof
08/14/2013CN103242218A N-substituted pipecolic acid derivative, as well as preparation method and application thereof
08/14/2013CN103242215A Preparation method of lenalidomide intermediate
08/14/2013CN103242174A Amine-based compound and organic light-emitting diode including the same
08/14/2013CN103242116A Novel method for preparing arylamine through reducing aromatic nitro compound
08/14/2013CN102675283B Method for preparing bepotastine by condensation under acidic condition
08/14/2013CN102408413B Anticoccidial compound, and preparation method and use thereof
08/14/2013CN102260243B Saquinavir succinic acid half ester salt and its preparation
08/14/2013CN102143955B 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
08/14/2013CN102123988B Squaric acid derivatives as inhibitors of nicotinamide
08/14/2013CN102060843B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/14/2013CN102007114B Process for producing anthranilamide compound
08/14/2013CN101993415B Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof
08/14/2013CN101981024B Acenaphthopyridine derivative, material of light-emitting element, light-emitting element, light-emitting device, and electronic appliance
08/14/2013CN101945879B Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
08/14/2013CN101903348B Pyrazole-substituted arylamides
08/14/2013CN101838260B Dihydropyrrolones derivative as Caspase-3 inhibitor
08/14/2013CN101743229B Quinazolinamide derivatives
08/14/2013CN101490038B Pyrimidine derivatives as ALK-5 inhibitors
08/14/2013CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors
08/14/2013CN101331124B Novel vanilloid receptor ligands and their use for producing medicaments
08/13/2013US8507722 Hepatitis C virus inhibitors
08/13/2013US8507686 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
08/13/2013US8507685 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
08/13/2013US8507682 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors
08/13/2013US8507681 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
08/13/2013US8507671 Insecticidal substituted azinyl derivatives
08/13/2013US8507535 Methyl-pyrrolidine ether derivatives
08/13/2013US8507531 Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer
08/13/2013US8507524 Modulators of ATP-binding cassette-transporters
08/13/2013US8507523 anticarcinogenic agents such as 6,7-dimethoxy-1-(4-pyridin-4-ylbenzyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride salt, used for treating gliomas or retinoblastomas; side effect reduction
08/13/2013US8507521 Heterocyclic derivatives
08/13/2013US8507516 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
08/13/2013US8507512 Soluble guanylate cyclase activators
08/13/2013US8507498 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
08/13/2013US8507493 Amide and amidine derivatives and uses thereof
08/13/2013US8507490 Tetrasubstituted pyridazine hedgehog pathway antagonists
08/13/2013US8507474 Anthelmintic agents and their use
08/13/2013US8507472 Bicyclic pyridinylpyrazoles
08/13/2013CA2690753C Sulfonamide compound and crystal thereof
08/13/2013CA2684563C 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
08/13/2013CA2670892C Substituted diazepan compounds as orexin receptor antagonists
08/13/2013CA2649822C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/13/2013CA2619566C 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
08/13/2013CA2619448C 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
08/13/2013CA2611892C Tetrahydroquinoline derivatives as motor protein eg5 inhibitors and antitumor agents
08/13/2013CA2580409C Triazole derivative or salt thereof
08/08/2013WO2013116182A1 Heterocyclic compounds as inhibitors of leukotriene production
08/08/2013WO2013114232A1 Process for preparation of crystalline form l of ilaprazole
08/08/2013WO2013113863A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113841A1 Novel therapeutic agents
08/08/2013WO2013113791A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113789A1 N-thio-anthranilamide compounds and their use as pesticides
08/08/2013WO2013113788A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113787A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113782A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113781A1 Fungicidal pyrimidine compounds i
08/08/2013WO2013113778A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113776A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113773A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113720A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113719A1 Fungicidal pyrimidine compounds ii
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 1080